HB1839
Type: B Origin: House USA Comments: 0

Combating Illicit Xylazine Act

AI Summary
User Reviews

The "Combating Illicit Xylazine Act" is a federal bill aimed at addressing the misuse and trafficking of xylazine, a sedative commonly used in veterinary medicine that has increasingly been abused for illicit purposes, such as adulterating drugs like heroin. The main provisions of the bill include enhancing penalties for those involved in the illegal distribution of xylazine, increasing resources for law enforcement to combat its trafficking, and promoting public awareness about the dangers associated with its misuse. The bill seeks to curb the harmful impact of xylazine abuse on individuals and communities by targeting its illicit supply chain and raising awareness about its risks.

Bill Activity

  • 2023-03-28: Introduced in House

  • 2023-03-28: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  • 2023-04-07: Referred to the Subcommittee on Health.

Issaquah, WA Ratings
C
Overall Ratings
B

Overall Bill Rating

0.0

Sponsors (1)

Cosponsors (100)

Text Versions (1)
Bill Discussion Board

Share your views on the Bill

User Icon

Min. 50 characters required  |  (0/1000 Character)

Contributions (0)
Add Contribution+2 pts.

Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.